108 related articles for article (PubMed ID: 12297853)
1. Extracorporeal albumin dialysis in acute-on-chronic liver failure: will it stand the test of time?
Sen S; Jalan R; Williams R
Hepatology; 2002 Oct; 36(4 Pt 1):1014-6. PubMed ID: 12297853
[No Abstract] [Full Text] [Related]
2. Correction of disturbed pathophysiology of hepatic failure by albumin dialysis.
Williams R
Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):19-24. PubMed ID: 18234633
[No Abstract] [Full Text] [Related]
3. Preliminary results of a phase I trial evaluating an extracorporeal hepatic support device utilizing albumin dialysis.
Awad SS; Swaniker F; Bartlett RH
Z Gastroenterol; 2001 Jun; 39 Suppl 2():22-3. PubMed ID: 16215890
[No Abstract] [Full Text] [Related]
4. Amounts of bile acids and bilirubin removed during single-pass albumin dialysis in patients with liver failure.
Benyoub K; Muller M; Bonnet A; Simon R; Gazon M; Duperret S; Aubrun F; Viale JP
Ther Apher Dial; 2011 Oct; 15(5):504-6. PubMed ID: 21974706
[No Abstract] [Full Text] [Related]
5. Extracorporeal liver support with multipass albumin dialysis or plasmapheresis and filtering systems in acute liver failure.
Bacher A
Liver Int; 2011 Sep; 31 Suppl 3():16-8. PubMed ID: 21824278
[TBL] [Abstract][Full Text] [Related]
6. [The clinical experience with MARS and Prometheus procedures].
Hydzik P; Gawlikowski T; Ciszowski K; Sułlek M
Przegl Lek; 2007; 64(4-5):352-4. PubMed ID: 17724911
[TBL] [Abstract][Full Text] [Related]
7. First experience in Spain with MARS in three patients with advanced liver failure.
Aviles J; Macia M; Perez F; Moreno A; Navarro JF; Morales S; Medina ML; Aguiar R; Garcia J
Z Gastroenterol; 2001 Jun; 39 Suppl 2():20-1. PubMed ID: 16215889
[No Abstract] [Full Text] [Related]
8. Artificial liver support as a bridge to orthotopic liver transplantation in a case of acute liver dysfunction on non-alcoholic steatohepatitis (NASH).
Gaspari R; Pennisi MA; Mignani V; Gasbarrini A; Mercurio G; Di Campli C; Conti G; Gentiloni Silveri N; Proietti R
Z Gastroenterol; 2001 Jun; 39 Suppl 2():15-7. PubMed ID: 16215887
[No Abstract] [Full Text] [Related]
9. Bench-to-bedside review: current evidence for extracorporeal albumin dialysis systems in liver failure.
Karvellas CJ; Gibney N; Kutsogiannis D; Wendon J; Bain VG
Crit Care; 2007; 11(3):215. PubMed ID: 17567927
[TBL] [Abstract][Full Text] [Related]
10. Removal of bile acids by two different extracorporeal liver support systems in acute-on-chronic liver failure.
Stadlbauer V; Krisper P; Beuers U; Haditsch B; Schneditz D; Jung A; Putz-Bankuti C; Holzer H; Trauner M; Stauber RE
ASAIO J; 2007; 53(2):187-93. PubMed ID: 17413559
[TBL] [Abstract][Full Text] [Related]
11. Effect of extracorporeal liver support by molecular adsorbents recirculating system and Prometheus on redox state of albumin in acute-on-chronic liver failure.
Oettl K; Stadlbauer V; Krisper P; Stauber RE
Ther Apher Dial; 2009 Oct; 13(5):431-6. PubMed ID: 19788461
[TBL] [Abstract][Full Text] [Related]
12. [The assessment of albumin liver dialysis--MARS efficacy in the treatment of Amanita phalloides poisoning].
Sein Anand J; Chodorowski Z; Wiśniewski M; Waldman W
Przegl Lek; 2007; 64(4-5):255-7. PubMed ID: 17724880
[TBL] [Abstract][Full Text] [Related]
13. Methods of extracorporeal liver support for treatment of liver cell failure.
Adham M
Z Gastroenterol; 2001 Jun; 39 Suppl 2():1-5. PubMed ID: 16215880
[No Abstract] [Full Text] [Related]
14. Artificial liver support systems.
George J
J Assoc Physicians India; 2004 Sep; 52():719-22. PubMed ID: 15839451
[TBL] [Abstract][Full Text] [Related]
15. The decrease in cytokine concentration during albumin dialysis correlates with the prognosis of patients with acute on chronic liver failure.
Di Campli C; Zocco MA; Gaspari R; Novi M; Candelli M; Santoliquido A; Flore R; Tondi P; Proietti R; Gasbarrini G; Pola P; Gasbarrini A
Transplant Proc; 2005; 37(6):2551-3. PubMed ID: 16182740
[TBL] [Abstract][Full Text] [Related]
16. Systemic and regional hemodynamics in pigs with acute liver failure and the effect of albumin dialysis.
Ytrebø LM; Sen S; Rose C; Davies NA; Nedredal GI; Fuskevaag OM; Ten Have GA; Prinzen FW; Williams R; Deutz NE; Jalan R; Revhaug A
Scand J Gastroenterol; 2006 Nov; 41(11):1350-60. PubMed ID: 17060130
[TBL] [Abstract][Full Text] [Related]
17. Albumin-bound substances--a new target in liver failure therapy.
Mitzner S; Stange J; Klammt S; Peszynski P; Hickstein H; Korten G; Schmidt R
Z Gastroenterol; 2001 Jun; 39 Suppl 2():6-7. PubMed ID: 16215882
[No Abstract] [Full Text] [Related]
18. Acute-on-chronic liver failure: extracorporeal liver assist devices.
Hassanein TI; Schade RR; Hepburn IS
Curr Opin Crit Care; 2011 Apr; 17(2):195-203. PubMed ID: 21346566
[TBL] [Abstract][Full Text] [Related]
19. [Non-biological liver support in hepatic failure].
Schmidt LE; Larsen FS
Ugeskr Laeger; 2002 Jun; 164(24):3189-93. PubMed ID: 12082764
[TBL] [Abstract][Full Text] [Related]
20. Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure.
Laleman W; Wilmer A; Evenepoel P; Elst IV; Zeegers M; Zaman Z; Verslype C; Fevery J; Nevens F
Crit Care; 2006; 10(4):R108. PubMed ID: 16859530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
